The global demand for intra-aortic balloons, which is expected to hit a value of US$ 471.8 Mn by 2027, will be impacted by growing product recalls and increasing concerns regarding patient safety. This reflects a 2.7 percent CAGR over the 2017–2027 forecast period. The global intra-aortic balloon pump market offers an absolute dollar opportunity of US$ 10.9 million in 2018 compared to 2017 and an incremental chance of US$ 111 million between 2017 and 2027.
Rising intra-aortic balloon pump acceptance in emerging economies
Due to the growing prevalence of coronary artery diseases such as unstable angina and myocardial infarction (NSTEMI) and chronic heart diseases, emerging countries in the Asia Pacific region such as China and India are hotspots for investment.